123 related articles for article (PubMed ID: 31626554)
1. MnCaCs-Biomineralized Oncolytic Virus for Bimodal Imaging-Guided and Synergistically Enhanced Anticancer Therapy.
Huang LL; Li X; Zhang J; Zhao QR; Zhang MJ; Liu AA; Pang DW; Xie HY
Nano Lett; 2019 Nov; 19(11):8002-8009. PubMed ID: 31626554
[TBL] [Abstract][Full Text] [Related]
2. Tumor-targeted delivery of copper-manganese biomineralized oncolytic adenovirus for colorectal cancer immunotherapy.
Li YS; Ye LY; Luo YX; Zheng WJ; Si JX; Yang X; Zhang YN; Wang SB; Zou H; Jin KT; Ge T; Cai Y; Mou XZ
Acta Biomater; 2024 Apr; 179():243-255. PubMed ID: 38458511
[TBL] [Abstract][Full Text] [Related]
3. Polymeric oncolytic adenovirus for cancer gene therapy.
Choi JW; Lee YS; Yun CO; Kim SW
J Control Release; 2015 Dec; 219():181-191. PubMed ID: 26453806
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor Activity.
Garofalo M; Iovine B; Kuryk L; Capasso C; Hirvinen M; Vitale A; Yliperttula M; Bevilacqua MA; Cerullo V
Mol Cancer Ther; 2016 Apr; 15(4):651-60. PubMed ID: 26861248
[TBL] [Abstract][Full Text] [Related]
5. Using a magnetic field to redirect an oncolytic adenovirus complexed with iron oxide augments gene therapy efficacy.
Choi JW; Park JW; Na Y; Jung SJ; Hwang JK; Choi D; Lee KG; Yun CO
Biomaterials; 2015 Oct; 65():163-74. PubMed ID: 26164117
[TBL] [Abstract][Full Text] [Related]
6. pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis.
Choi JW; Jung SJ; Kasala D; Hwang JK; Hu J; Bae YH; Yun CO
J Control Release; 2015 May; 205():134-43. PubMed ID: 25575865
[TBL] [Abstract][Full Text] [Related]
7. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
[TBL] [Abstract][Full Text] [Related]
8. Genetically Engineered Cell Membrane Nanovesicles for Oncolytic Adenovirus Delivery: A Versatile Platform for Cancer Virotherapy.
Lv P; Liu X; Chen X; Liu C; Zhang Y; Chu C; Wang J; Wang X; Chen X; Liu G
Nano Lett; 2019 May; 19(5):2993-3001. PubMed ID: 30964695
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy.
Kwon OJ; Kang E; Choi JW; Kim SW; Yun CO
J Control Release; 2013 Aug; 169(3):257-65. PubMed ID: 23562633
[TBL] [Abstract][Full Text] [Related]
10. Systemic Administration and Targeted Delivery of Immunogenic Oncolytic Adenovirus Encapsulated in Extracellular Vesicles for Cancer Therapies.
Garofalo M; Villa A; Rizzi N; Kuryk L; Mazzaferro V; Ciana P
Viruses; 2018 Oct; 10(10):. PubMed ID: 30322158
[TBL] [Abstract][Full Text] [Related]
11. A novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous route.
Wang Z; Yu B; Wang B; Yan J; Feng X; Wang Z; Wang L; Zhang H; Wu H; Wu J; Kong W; Yu X
Oncotarget; 2016 Jul; 7(30):47287-47301. PubMed ID: 27323824
[TBL] [Abstract][Full Text] [Related]
12. Virus combinations and chemotherapy for the treatment of human cancers.
Kumar S; Gao L; Yeagy B; Reid T
Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
[TBL] [Abstract][Full Text] [Related]
13. Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity.
Fernández-Ulibarri I; Hammer K; Arndt MA; Kaufmann JK; Dorer D; Engelhardt S; Kontermann RE; Hess J; Allgayer H; Krauss J; Nettelbeck DM
Int J Cancer; 2015 May; 136(9):2228-40. PubMed ID: 25303768
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in oncolytic adenovirus therapies for cancer.
Rosewell Shaw A; Suzuki M
Curr Opin Virol; 2016 Dec; 21():9-15. PubMed ID: 27379906
[TBL] [Abstract][Full Text] [Related]
15. A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.
Wang Y; Liu T; Huang P; Zhao H; Zhang R; Ma B; Chen K; Huang F; Zhou X; Cui C; Liu X
Oncotarget; 2015 May; 6(15):13564-78. PubMed ID: 25980438
[TBL] [Abstract][Full Text] [Related]
16. Chapter four--Design of improved oncolytic adenoviruses.
Alemany R
Adv Cancer Res; 2012; 115():93-114. PubMed ID: 23021243
[TBL] [Abstract][Full Text] [Related]
17. Targeting gene-virus-mediated manganese superoxide dismutase effectively suppresses tumor growth in hepatocellular carcinoma in vitro and in vivo.
Huang F; Ma B; Wang Y; Xiao R; Kong Y; Zhou X; Xia D
Cancer Biother Radiopharm; 2014 Dec; 29(10):403-11. PubMed ID: 25414976
[TBL] [Abstract][Full Text] [Related]
18. Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.
Na Y; Choi JW; Kasala D; Hong J; Oh E; Li Y; Jung SJ; Kim SW; Yun CO
J Control Release; 2015 Dec; 220(Pt B):766-82. PubMed ID: 26471393
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic Adenovirus Coated with Multidegradable Bioreducible Core-Cross-Linked Polyethylenimine for Cancer Gene Therapy.
Choi JW; Nam JP; Nam K; Lee YS; Yun CO; Kim SW
Biomacromolecules; 2015 Jul; 16(7):2132-43. PubMed ID: 26096567
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic potential of an E4-deficient adenovirus that can recognize the stabilization of AU-rich element containing mRNA in cancer cells.
Yanagawa-Matsuda A; Mikawa Y; Habiba U; Kitamura T; Yasuda M; Towfik-Alam M; Kitagawa Y; Minowa K; Shindoh M; Higashino F
Oncol Rep; 2019 Feb; 41(2):954-960. PubMed ID: 30431137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
